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Abstract
Introduction Bacterial cell characteristics change signif-
icantly during differentiation between planktonic and bio-
film states. While established methods exist to detect and
identify transcriptional and proteomic changes, metabolic
fluctuations that distinguish these developmental stages
have been less amenable to investigation.
Objectives The objectives of the study were to develop a
robust reproducible sample preparation methodology for
high throughput biofilm analysis and to determine differ-
ences between Staphylococcus aureus in planktonic and
biofilm states.
Methods The method uses bead beating in a chloroform/
methanol/water extraction solvent to both disrupt cells and
quench metabolism. Verification of the method was per-
formed using liquid-chromatography-mass spectrometry.
Rawmass-spectrometry datawas analysed using an in-house
bioinformatics pipe-line incorporating XCMS, MzMatch
and in-house R-scripts, with identifications matched to
internal standards and metabolite data-base entries.
Results We have demonstrated a novel mechanical bead
beating method that has been optimised for the extraction
of the metabolome from cells of a clinical Staphylococcus
aureus strain existing in a planktonic or biofilm state. This
high-throughput method is fast and reproducible, allowing
for direct comparison between different bacterial growth
states. Significant changes in arginine biosynthesis were
identified between the two cell populations.
Conclusions The method described herein represents a
valuable tool in studying microbial biochemistry at a
molecular level. While the methodology is generally
applicable to the lysis and extraction of metabolites from
Gram positive bacteria, it is particularly applicable to
biofilms. Bacteria that exist as a biofilm are shown to be
highly distinct metabolically from their ‘free living’
counterparts, thus highlighting the need to study microbes
in different growth states. Metabolomics can successfully
distinguish between a planktonic and biofilm growth state.
Importantly, this study design, incorporating metabo-
lomics, could be optimised for studying the effects of
antimicrobials and drug modes of action, potentially pro-
viding explanations and mechanisms of antibiotic resis-
tance and to help devise new antimicrobials.
Keywords Metabolomics  Metabolite extraction 
Biofilms  S. aureus
1 Introduction
Metabolomics aims to measure comprehensively the
metabolic profile of a system (Fiehn 2002). The term
metabolomics was first coined in 1998 (Oliver et al. 1998),
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although the concept of ‘metabolic profiling’ can be dated
to the 1970s (Horning and Horning 1971). Metabolomics
provides a ‘snap-shot’ of cell metabolism and can highlight
discrete changes in metabolic pathways and the abundance
of biological small molecule metabolite intermediates.
Using untargeted metabolomics, chemical effects across
the gamut of metabolic processes can be studied providing
greater understanding of the biological responses from
single cells to the complex system/organism level (Ni-
cholson and Lindon 2008).
Metabolomic techniques have been applied to bacterial
cells (Tang 2011; Liebeke et al. 2012), although not
without significant hurdles. Current microbial extraction
and metabolic quenching methods have a number of
associated problems (de Koning and van Dam 1992; Bolten
et al. 2007). Often, metabolite degradation or inadequate
quenching of metabolism during extraction, media con-
tamination, or failure to lyse the bacterial cell, can lead to
artefactual and/or variable results (Bolten et al. 2007). In
addition, many of the methods developed are primarily for
studies of Gram-negative bacteria, which are poorly suited
to Gram-positive bacteria because of their dense peptido-
glycan cell wall (Maharjan and Ferenci 2003). Many bac-
teria also have the capacity to form biofilms on a range of
biological and abiotic substrates (O’Toole et al. 2000).
Here, an extracellular matrix (ECM) encases bacteria,
altering phenotype, biochemistry and transcriptome in
comparison to free floating, planktonic, cells. Biofilms also
alter the ability to extract metabolites from bacteria as well
as making them recalcitrant to antimicrobial chemotherapy
(Ramage et al. 2003; Drenkard and Ausubel 2002).
Moreover, the transition from planktonic growth to biofilm
formation can influence the metabolic profile of the bac-
teria (Gjersing et al. 2007). These factors make the meta-
bolic analysis of clinically important pathogens
problematic.
Metabolomics offers novel methods to study funda-
mental processes involved in microbial biofilm formation,
their response to antimicrobial chemotherapy, and may also
lead to the identification of novel biomarkers that could
improve clinical diagnostics. To date, limited investiga-
tions have been performed on metabolomics of biofilms
using nuclear magnetic resonance (NMR) spectrometry to
study molecular differences between planktonic cells and
biofilms (Zhang and Powers 2012; Ammons et al. 2014;
Gjersing et al. 2007).
This paper aims to describe a novel method applicable to
study biofilm metabolism in the model Gram-positive
pathogen Staphylococcus aureus. Here, we report for the first
time an optimised method for the extraction of the metabo-
lome directly from a biofilm in parallel to cells living in
suspension. Through liquid-chromatography-mass-spec-
trometry (LC–MS) metabolomics we demonstrate that the
method is highly reproducible, further showing significant
differences in metabolism between planktonic and biofilm
cells grown under identical conditions. We focus on differ-
ences in arginine biosynthesis between the two growth states,
thus providing insights into the biological properties of this
important nosocomial pathogen.
2 Materials and methods
All reagents and chemicals were purchased from Fisher
Scientific, Loughborough, UK, at HPLC grade, unless
stated otherwise.
2.1 Bacteria culture
A clinical S. aureus strain, LHSKBClinical, (Stipetic et al.
2015), was used throughout this study. This was cultured
on Brain Heart Infusion (BHI) agar plates or in BHI broth
media (Oxoid, Basingstoke, UK). For all experiments,
single colonies were taken from a plate and inoculated into
liquid media. Cultures were grown overnight at 37 C to
stationary phase growth, which was used for subsequent
planktonic and biofilm studies. Bacteria were grown under
aerobic conditions.
2.2 Planktonic cell preparation
For planktonic cell preparation, 200 lL of the stationary
phase overnight culture were added to wells of a 96-well
microtitre plate (Corning Incorporated, New York, USA),
centrifuged at 19009g at 4 C for 3 min, and the spent
media removed. Subsequently, 200 ll of 10 mM ammo-
nium bicarbonate (Sigma-Aldrich, Dorset, UK) was added,
the pellet resuspended, cells were washed by centrifugation
at 19009g at 4 C for 3 min, and the supernatant was
removed, providing a pellet for bead beating as described
below.
2.3 Biofilm cell preparation
Biofilms were prepared by adding standardised S. aureus
culture at 1 x 108 cells/ml in BHI into a 96-well microtitre
plate, which was then statically incubated for 18 h at 37 C
under aerobic conditions. Following incubation, the
supernatant was removed and the biofilms were washed in
sterile 10 mM ammonium bicarbonate.
2.4 Biofilm SEM
Scanning electron microscopy (SEM) was performed on
parallel samples of S. aureus biofilms cultivated directly
onto ThermanoxTM cover-slips (Nunc, Roskilde,
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Denmark), processed and imaged as previously described
by Erlandsen et al. (2004).
2.5 Metabolite extraction using bead beating
Metabolites were extracted directly within the wells of a
microtitre plate by adding 200 ll of 0.1 mm acid washed,
glass beads (Sigma-Aldrich) and ice cold (-20 C) solvent
solution (1 g of beads to 1 ml of chloroform:
methanol:ddH2O [ratio of 1:3:1]).
A 96-well microtitre plate was used, primarily so that
biofilms could be extracted in situ and so that 24 inde-
pendent replicates could be performed for each condition,
including media only negative controls. The plate was then
sealed with a 96-well Cap Mat (Greiner Bio-One, Stone-
house, UK) and bead beaten on a cell disrupter (Disrupter
Genie) (Scientific industries, Inc., New York, USA),
operating at a speed of 3000 RPM, at 4 C continuously for
10 min. The plates were then centrifuged at 19009g at
4 C for 10 min, to remove beads and cell debris. The
supernatant was then removed and stored at -80 C until
MS analysis. Extractions and metabolomics results repre-
sent one experiment with 24 replicates intended to
demonstrate the utility of the method.
2.6 Comparative methods for metabolite extractions
Two additional, previously published methods for Gram
positive bacterial cell lysis (Soga et al. 2002; Soga et al.
2003; Takahashi et al. 2010), were compared to the bead
beating method. Modifications to the published methods
were made, and are described in detail in Online resource
1, but briefly, extraction solvents were altered to a chlo-
roform/methanol/water 1:3:1 mix and water/PBS washes
were replaced with 10 mM ammonium bicarbonate to
ensure differences between the methods were due to lysis
rather than extraction solvent. Sonication was altered from
30 s with a sonic probe to 30 min in a sonic bath to min-
imise heating and provide compatibility with microtitre
plate extractions. Each extraction method was performed in
triplicate.
2.7 Metabolomic workflow, data acquirement
and analysis
Samples were analysed by hydrophilic interaction liquid
chromatography (HILIC) -mass spectrometry (LC–MS)
(UltiMate 3000 RSLC (Thermo Fisher, San Jose, California,
USA) using a 150 x 4.6 mm ZIC-pHILIC column (Merck
SeQuant, Umea, Sweden) running at 300 ll/min and Orbi-
trap Exactive (Thermo Fisher) detection. Mass spectrometer
parameters were: 50,000 resolving power in positive/nega-
tive switching mode. Electrospray ionisation (ESI) voltage
was 4.5 kV in positive and 3 kV in negative modes. Buffers
consisted of A: 20 mM ammonium carbonate in H2O and B:
Merck SeQuant: acetonitrile. The gradient ran from 20 %A:
80 %B to 80 %A: 20 % B in 15 min, followed by a wash at
95 %A: 5 %B for 3 min, and equilibration at 20 %A: 80 %
B for 5 min. Raw mass spectrometry data was processed
using our standard pipeline, consisting of XCMS (Smith
et al. 2006) (for peak picking), MzMatch (Scheltema et al.
2011) (for filtering and grouping) and in-house R-scripts (for
further filtering, post-processing and identification). Peaks
were visualised using PeakML Viewer (Scheltema et al.
2011). Coremetabolite identificationswere validated against
a panel of unambiguous authentic pure standards using
accurate mass and retention time (Rt) and therefore could be
classified using the alphanumeric metabolite coding
scheme as HRMS1a Rta as described by Sumner et al. (2014).
Additional putative identifications were assigned by accu-
rate mass along with a Rt prediction algorithm (Creek et al.
2011) and therefore could be classified as HRMS1PL (Sumner
et al. 2014). Quantile normalisation was carried out across
the data, normalising both data sets (Bolstad et al. 2003).
Once identified and filtered, detected peak intensities were
logged (base 2) and quantitation was performed on sets of
biological replicates by applying differential statistics to
generate P values. Metabolites with apparently different
levels were assessed using Bayes moderated t-tests (Smyth
2004). Benjamini and Hochberg false discovery rate
adjustment for multiple testing was applied (Hochberg and
Benjamini 1990) and the resulting data was used to query
KEGG (Kyoto Encyclopaedia of Genes and Genomes data
base) for pathway analysis (Kanehisa and Goto 2000).
Statistics, including principal component analysis (PCA),
were performed and presented using R, employing appro-
priate standard R libraries and Microsoft Excel. ChemDraw
Std version 14.0 was used to draw metabolic pathways and
GraphPad Prism 4 used to create figures. Comparative
metabolomic analysis of extraction methods was further
processed using the IDEOM software (Creek et al. 2012),
without normalisation applied.
3 Results
3.1 Liquid Chromatography-Mass Spectrometry
metabolomics for S. aureus planktonic cell
and biofilm analysis following sample bead-
beating and metabolome extraction
Static biofilms were grown using BHI, as an optimal
medium based on a study of S. aureus biofilm formation in
1000 clinical isolates (Smith et al. 2008). SEM imaging
(Fig. 1) provided qualitative data illustrating that the
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S. aureus clinically-derived strain used herein forms a
biofilm. Figure 1 shows key characteristics of biofilm for-
mation: cell clustering of cells attached and colonised to
the surface of the cover-slip, and ECM production
(O’Toole et al. 2000; Periasamy et al. 2012).
Once bacterial culture and biofilm cultivation had been
established, an extraction platform was developed that
would enable both planktonic and biofilm cells to be
extracted simultaneously using a mechanical bead beating
method.
A mechanical cell lysis method was optimised using
0.1 mm beads, as recommended for bacterial species by the
cell disrupter manufacturer’s guidelines (Scientific indus-
tries 2014). Initial bead beating studies demonstrated that
10 min induced[95 % cell death (data not shown).
Greiner Bio-One Cap mats were found to be optimal for
sealing plates during lysis, while the use of plastic-paraffin
film resulted in sample leakage and cross contamination
between samples. Ammonium bicarbonate was used for all
wash stages due to its LC–MS compatibility and moderate
pH buffering (Cassou et al. 2014; Faijes et al. 2007;
Hedges et al. 2013). Extracting the metabolites at 4 C in
chloroform/methanol/water slowed (Laidler 1984) and
quenched (t’Kindt and 2010) cellular metabolic activity
during extraction.
A significant consideration for metabolomics is the
amount of material (metabolite extraction) required for an
effective analysis. Using the LC–MS set-up utilised here, a
minimum sample volume of 10 ll of metabolite extraction
with a minimum metabolite concentration dependent on the
molecule studied, but detection limits generally in the
micromolar range for small molecules (Gross 2011), were
required for effective analysis. Sufficient material for
detection and quantitation of hundreds of metabolites was
obtained from a biofilm covering the well base of a 96-well
microtitre plate.
3.2 Comparison with alternative lysis methods
The extraction process described herein was compared to
the methods described by Soga et al. (2002, 2003) and
Takahashi et al. (Takahashi et al. 2010). No viable bacteria
were found after analysis of the pellet using any of the
described methods (data not shown). Total useable signal
of the metabolites from each method showed no significant
difference between the lysis methods (t test P values of
0.12—bead beating vs. filtration, 0.10—bead beating vs.
sonication for positive mode and 0.15—bead beating vs.
filtration, 0.09 bead beating vs. sonication for negative
mode data) (see Online resource 2). Further analysis of the
extractions performed using the filtration method, however,
demonstrated a general decrease in the intensities of well
characterised metabolites. Of 84 ‘identified’ metabolites,
31 are significantly lower in intensity with only 3 signifi-
cantly higher, while the bead beating and sonicationmethods
gave similar results overall (see Online resource 2).
3.3 Liquid-chromatography-mass spectrometry
(LC–MS) data analysis
Data analysis of cell extractions derived from planktonic
shaking cultures compared to static biofilm extractions
yielded 530 significantly changing peaks with an adjusted
P value of\0.05 (null hypothesis: there is no difference
between planktonic cell and biofilm extractions, reject null
hypothesis). Of these, 151 metabolites demonstrated a
significant up-regulation in expression in planktonic cells
compared to biofilms, with log2 fold changes of C1.
Conversely, 177 were found to be significantly up-regu-
lated in biofilms as compared to planktonic cells with log2
fold changes of C1. Metabolites were identified by
matching mass and Rt to internal standards or annotated by
mass-matching to a database entry. Data analyses, includ-
ing raw peak data, metabolite identification, planktonic
compared to biofilm samples analysis, and Rt errors are
shown in Online Resource 3.
Fig. 1 Scanning Electron Microscopy images of a clinical S. aureus
strain biofilm, cultivated in BHI directly on ThermanoxTM cover-slips
for 18–20 h. a 5009 magnification, b 50009 magnification. Arrows
highlight areas of extracellular matrix
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Through plotting the average peak intensities between
replicates of peaks listed in Table 1 (Online Resource 4),
demonstrates that the deviation between replicates in the
sample group is relatively small, and highlights differences
in the fold changes between sample groups. All individual
peak intensities are shown in Online Resource 3, raw data.
PCA of metabolomic data sets of planktonic cells and
biofilm samples, analysed using LC–MS, revealed clus-
tering of biological replicates (Fig. 2). The plot shows
variation in detected metabolites between both groups.
Principal components 1 and 2 are responsible for 78.4 and
10.91 % of the variation, respectively. Furthermore, the
plot shows an outlier in the biofilm data set not clustered
with the other replicates along PCA 2. This sample displays
low or zero peak intensities in most metabolites compared
to other replicates in the set (see Online Resource 3, raw
data, sample B20) and is likely to be due to a failed
injection.
3.4 Arginine Metabolism- an example
of a metabolic pathway showing significant
changes between planktonic and biofilm samples
Metabolites were matched to pre-existing pathways defined
by the KEGG database (Kanehisa and Goto 2000). The
results yielded 129 pathways containing a minimum of two
identified (HRMS1a Rta) or annotated (HRMS
1
PL) metabo-
lites that demonstrated significant (P\ 0.05) changes in
expression between planktonic cells and biofilm samples.
Table 2 lists the top 20 of these pathways annotated with
the most detected metabolites. All further identified and
annotated compounds grouped into pathways are listed in
Online Resource 3.
After mapping the data to arginine biosynthesis (KEGG
pathway 00220), with filtering based on the available
genome sequence of this isolate, it was found that 4
identified (HRMS1a Rta) and 5 putatively annotated
Table 1 Arginine Biosynthesis metabolites identified from planktonic and biofilm data sets
Peak number Metabolite Elemental formula KEGG IDa Metabolite codeb Mass [M–H] (Da) Rt
c (sec) Log2 fold change
d
2782 Aspartate C4H7NO4 C00049 HRMS1PL 132.0302 749.1 1.577
2873 Glutamate C5H9NO4 C00025 HRMS1a Rta 146.0458 725.7 1.0159
2981 Glutamine C5H10N2O3 C00064 HRMS1a Rta 145.0618 781.3 n/a
(e)
3171 Citrulline C6H13N3O3 C00327 HRMS1a Rta 174.0884 813.1 3.5413
3252 N-Acetyl-L-
glutamate
C7H11NO5 C00624 HRMS1a Rta 188.0564 691.1 4.3654
3505 L-Arginosuccinate C10H18N4O6 C03406 HRMS1PL 289.1156 800.5 n/a
f
3608 N-Acetyl-L-citrulline C8H15N3O4 C15532 HRMS1PL 216.099 594.1 5.049
3636 N-Acetyl-ornithine C7H14N2O3 C00437 HRMS1a Rta 173.0931 791.2 1.068
3838 Arginine C6H14N4O2 C00062 HRMS1PL 173.1044 1304.1 1.3781
a See reference Kanehisa and Goto 2000
b See reference Sumner et al. 2014
c Retention time
d Log2 fold change in expression of metabolite between planktonic and biofilm data sets
e Not available, fold change unable to be formulated as peak intensities did not significantly change between sample sets
f Not available, fold change unable to be formulated as only detected in the planktonic data set and not in the biofilm data set
Fig. 2 Principal component analysis (PCA) plots of Planktonic (blue)
and biofilm (red) metabolomic data sets, utilising a 10 min bead
beating extraction method; beads in a 50:50 suspension in extraction
solvent of chloroform; methanol; water (ratio 1:3:1), followed by
liquid-chromatography-mass spectrometry. Red and blue data plots
represent planktonic cells and biofilm biological sample replicates,
respectively. n = 24 (Color figure online)
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(HRMS1PL) (total of 9) metabolites are involved in this
pathway in S. aureus (Table 1 and Fig. 3). Of these, 6
metabolites (2 identified and 4 annotated) were seen to
have significant (P\ 0.05) log2 fold changes between
planktonic and biofilm sample sets. Peak annotation results
of the 9 identified or annotated arginine biosynthesis
metabolites detected in negative mode are listed in Table 1.
A number of metabolites were identified or annotated in
both data sets were a fold-change difference in intensity
could be calculated (Table 1), however L-arginosuccinate
was detected in the planktonic data set, displaying a peak in
all sample replicates, but not detected in the biofilm data
set. Glutamine was identified in both planktonic and bio-
film data sets, however its peak intensities did not signifi-
cantly change between sample sets. Peak intensity graphs
for the peaks listed in Table 1 are shown in Online
Resource 5.
4 Discussion
Most bacteria possess the ability to live in suspension or as
an adhered community on a surface. Novel ways to study
the distinct differences in metabolism between these two
states are much needed so that differences can be exploited
with the development of new antibiotics, in addition to
understanding fundamental biological processes. Further to
this, studying Gram-positive bacteria and their intracellular
metabolic intermediates comes with additional complica-
tions due to the robustness of the thick peptidoglycan cell
wall. Data presented herein describes a novel metabolite
extraction method utilising a direct bead beating method
for biofilms cultivated in a 96-well format, and down-
stream analysis to compare planktonic and biofilm cells.
Many previously published approaches for biofilm inves-
tigations use 96-well plates, allowing the bacterial culture
Table 2 Top 20 metabolic pathways that have intermediate and end-product metabolites that display significant changes in intensity between
planktonic cells and biofilm samples
Pathway namea KEGG map
IDa
Number of
metabolitesb
Annotated
(HRMS1PL)
c
Identified
(HRMS1a Rta)
d
Coveragee
(%)
P vs.
Bf
Arginine and proline metabolism/arginine biosynthesis 00330/00220 90 49 5 60 33
Protein digestion and absorption 04974 47 22 7 61.7 19
Tyrosine metabolism 00350 76 35 2 48.7 18
Histidine metabolism 00340 45 25 3 62.2 17
Galactose metabolism 00052 41 22 0 53.7 17
Aminoacyl-tRNA biosynthesis 00970 52 13 7 38.5 17
Cyanoamino acid metabolism 00460 46 31 1 69.6 16
Linoleic acid metabolism 00591 28 26 0 92.9 15
Limonene and pinene degradation 00903 64 53 0 82.8 15
C5-Branched dibasic acid metabolism 00660 32 20 4 75 14
Mineral absorption 04978 29 11 4 51.7 14
Phosphotransferase system (PTS) 02060 48 20 1 43.8 14
Two-component system 02020 41 10 6 39 14
Fructose and mannose metabolism 00051 51 16 0 31.4 14
Alanine, aspartate and glutamate metabolism 00250 24 15 2 70.8 13
Lysine degradation 00310 47 26 1 57.4 13
Glycine, serine and threonine metabolism 00260 51 27 2 56.9 13
Phenylalanine metabolism 00360 72 33 1 47.2 13
Pyrimidine metabolism 00240 66 28 5 50 12
Aminobenzoate degradation 00627 84 28 1 34.5 12
Purine metabolism 00230 92 16 9 27.2 12
Citrate cycle (TCA cycle) 00020 20 5 3 40 4
a In accordance with KEGG (Kyoto Encyclopaedia of Genes and Genomes data base) (Kanehisa and Goto 2000)
b Total number of metabolites in the pathway according to KEGG
c Number of annotated metabolites detected, metabolite code HRMS1PL (Sumner et al. 2014)
d Number of identified metabolites detected, metabolite code HRMS1a Rta (Sumner et al. 2014)
e Percentage of metabolites detected in the pathway (HRMS1PL and HRMS
1
a Rta)
f Number of metabolites detected (HRMS1PL and HRMS
1
a Rta) that show significant changes in expression profiles between Planktonic (P) and
biofilm (B) samples
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to adhere and develop on the bottom of the well (O’Toole
2011; Merritt et al. 2005; Christensen et al. 1985). The use
of a 96-well plate format has the additional benefit of
allowing for the substantial multiplexing of samples on the
same plate, as previously shown (Pierce et al. 2008; Lopez-
Ribot 2014; Srinivasan et al. 2013), including metabolite
analysis. Of note is that current published metabolite
extraction methods using bead beating focus on bacterial
cells living in a planktonic state (Liebeke et al. 2012). This
method has previously been shown to be beneficial in the
extraction of DNA and metabolites from Gram-positive
bacteria (Liebeke et al. 2012), pathogenic yeasts (Bolano
et al. 2001) and filamentous fungi (van Burik et al. 1998);
organisms that also possess a thick cell wall.
We were unable to use standard enzymatic disruption
methods (Salazar 2007), as this would introduce the
requirement for ambient temperature resulting in metabo-
lite degradation. However, we compared lysis using bead
beating with two other methods, filtration followed by
solvent extraction alone (2002; 2003), and sonication
(Takahashi et al. 2010). Solvent extraction was demon-
strated to be less effective than either bead beating or
sonication, while sonication was comparable to bead
beating, giving broadly similar results, so can be consid-
ered equally viable for analysis of planktonic Gram-posi-
tive bacteria. The limitation of sonication for biofilm
experiments include the complexities of sonicating uni-
formly across a multiwell plate and the time taken for bath
sonication methods.
Previous metabolomic literature has reported a number
of different solvent mixtures, demonstrating that the sol-
vent used and the temperature of extraction determines the
diversity of extracted metabolites (A et al. 2005). We used
chloroform methanol water 1:3:1 as an optimal extraction
solvent for our chromatography system (t’Kindt et al.
2010). A practical concern with using solvents such as
chloroform in cell-culture plastics is they can etch and
degrade plastic (Bawn and Wajid 1956). To avoid this,
glass coated wells and glass cell culture materials can be
used. However, previous work has demonstrated that bio-
film formation is altered on different substrates (Jansen and
Kohnen 1995; Ramage et al. 2003; Passerini de Rossi et al.
2007), so the use of plastic is often unavoidable. It was
found here that the effects of plastic degradation on overall
metabolomic results was minimal, possibly due to the poor
retention of hydrophobic compounds on the pHILIC col-
umn used, and if present could be compensated for with the
use of an appropriate negative control. In addition, any
plastic debris would also be pelleted along with the beads
at the end of the extraction process, and may be discarded
as the supernatant contains the metabolite extract.
One metabolic pathway that shows significant changes
is arginine metabolism, specifically the urea cycle (Fig. 3).
Several pathway intermediates: glutamate (HRMS1a Rta);
N-acetyl-L-glutamate (HRMS1a Rta); N-acetyl-L-citrulline
(HRMS1PL); aspartate (HRMS
1
PL); citrulline (HRMS
1
a Rta);
arginine (HRMS1PL); and N-acetyl-ornithine (HRMS
1
a Rta)
were detected to be significantly up-regulated in planktonic
samples or down-regulated in the biofilm samples, sug-
gesting that they are depleted in response to rapid flux
through this pathway. These results correlate with previous
studies that show significant changes in energy and cell
metabolism between planktonic cells and biofilms (Zhang
and Powers 2012; Ammons et al. 2014; Gjersing et al.
2007). Previous work using microarrays also showed up-
regulation of urea cycle genes in response to the formation
of biofilms in S. aureus (Resch et al. 2005). The amino acid
glutamine was identified (HRMS1a Rta) in both data sets but
was seen not to be changing in intensity between plank-
tonic and biofilm samples. S. aureus selectively extracts the
amino acid glutamine from its medium environment (Zhu
et al. 2007). The metabolite L-arginosuccinate was anno-
tated (HRMS1PL) to be found in planktonic samples only
and was absent from biofilm data. The absence in biofilms
may be because the metabolite is simply not present or
because its concentration is below the limits of detection of
our instrumentation. Previous studies by Zhu et al. (2007)
and Ammons et al. (2014) suggest that changes in amino
acid metabolism are a key feature differing in biofilms
compared to planktonic samples. Furthermore, these stud-
ies and Wu et al. (2010) suggest that arginine metabolism
and catabolism play an important role in biofilm survival.
We hypothesise that S. aureus may amplify flux through
the urea cycle to generate ammonia to restore pH balance
in response to the production of acid in the biofilm ECM
(Resch et al. 2005) due to anaerobic glycolysis. This cor-
relates with other studies that suggest that amino acid
catabolism is crucial for biofilm pH balance (Beenken et al.
2004; Resch et al. 2006; Resch et al. 2005; Zhu et al.
2007).
This study highlights key metabolic differences in
arginine metabolism between different bacterial growth
states. Findings presented here show that metabolism is
significantly altered by the same species of bacteria once a
sessile growth phase has been initiated. The changes
identified here between growth states could be evidence of
the bacteria responding to their changing environment and
trying to maintain a ‘status quo’ in chemical and pH bal-
ance, Bacteria should be thought of as dynamic entities
capable of displaying significantly altered phenotypes
without the necessity of genetic change. Because of this,
research into bacteria, and especially in the field of
antimicrobial testing and identification, should consider
different effects drugs may have on different stages of
growth.
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4.1 Method limitations
The biofilm cultivation method presented here in a 96-well
format, is based on a static growing biofilm. It is known
that biofilm phenotype can change depending on whether
cultivated in a static or flow system (Weaver et al. 2012;
Yarwood et al. 2004). However, the bead-beating extrac-
tion method described here can be applied to biofilms
cultivated on cover-slips used in a flow system, whereby
the cover-slip with attached biofilm is removed, washed
and placed in a bijou or similar for extraction. The
extraction method also does not discriminate between the
biofilm encased cells and the ECM. An appropriate ECM
and cell extraction method, suitable for mass-spectrometry
metabolomic samples is a target for future method devel-
opment. Finally, due to the resilience of the cells and the
time taken for full lysis and extraction, rapid metabolic
processes may still continue under these conditions, and
should be taken into account when evaluating the results.
5 Conclusions
The low-temperature, rapid, mechanical method coupled
with an extraction solvent to lyse the peptidoglycan cell
wall and extract the cellular metabolome from Gram-pos-
itive cells living in a planktonic state or as a biofilm is
described here. The method is shown to be a highly
reproducible platform to study cellular metabolism. PCA
clustering of 24 replicates, low variation in average peak
intensities and identification of significant (adjusted
P\ 0.05) changes in abundance of metabolite components
of the arginine biosynthesis pathway between data sets
highlights this reproducibility. Comparison with other
methods for lysis of planktonic bacteria further demon-
strates its utility for general bacterial metabolomics.
Data shows that significant changes in a number of
metabolic pathways, highlighting arginine biosynthesis,
take place between planktonic cells and biofilms. During
static culture, the biofilm’s adherence to the base of the well
will necessarily result in reduced access to oxygen, in con-
trast with a planktonic, shaking culture, and this change in
oxygen availability may be responsible for some or many of
the changes observed. However, is a general consensus that
metabolism is significantly altered in biofilm-forming cells
compared to planktonic cells (Zhang and Powers 2012;
Resch et al. 2006; Gjersing et al. 2007). The study of
microbial metabolism is challenging but provides crucial
insight into the biochemistry of bacteria. The added com-
plication of bacterial physiology responding to its environ-
ment adds to the complexity of such studies. The ability to
study metabolism provides the potential for inferences to be
gained, such as the modes of action of antimicrobials and the
identification of new metabolic drug targets. The insurgence
of antimicrobial resistance (Arias and Murray 2015) means
that research in this area is vitally important.
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bFig. 3 Arginine biosynthesis metabolic pathway showing both
detected metabolites identified by having mass and retention time
(Rt) matched to an internal standard (Bold and underlined) and
annotated metabolites matched to an accurate mass database entry.
Full molecular structures of the metabolites are given. Graphs
represent Log2 fold change of metabolite intensity/expression in
planktonic cells compared to biofilms. A positive fold change
indicates expression was either up regulated in planktonic samples
or down regulated in biofilm samples. Pathway and structures
annotated from the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database. Block arrows represent a direct link between
metabolites. Dashed arrows represent the presence of metabolite
intermediates that were not detected. Error bars represent 99.95 %
fold change confidence interval
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